1 documents found
Information × Registration Number 0107U007126, R & D request Title A phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose finding study of the safety and efficacy of daily CF101 administered orally, when added to weekly methotrexate in patients with active rheumatoid arthritis Head Свінціцький А.С., Registration Date 24-07-2007 Organization Bogomolets National Medical University, Ministry of Health of Ukraine popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
A phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose finding study of the safety and efficacy of daily CF101 administered orally, when added to weekly methotrexate in patients with active rheumatoid arthritis
Head: Свінціцький А.С.. A phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose finding study of the safety and efficacy of daily CF101 administered orally, when added to weekly methotrexate in patients with active rheumatoid arthritis. Bogomolets National Medical University, Ministry of Health of Ukraine. № 0107U007126
1 documents found

Updated: 2026-03-22


Роздрукувати цю сторінку